NASDAQ:PLRX | Cash Flow Statement | PLIANT THERAPEUTICS, INC.

Complete source-backed cash-flow history.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$22.37M
2026-03-31-$20.04M-$19.23M$0.00-$4.1M$74,000.00
2025-12-31-$23.58M-$17.79M$0.00$1.77M-$32.27M
2025-09-30-$26.3M
2025-06-30-$43.3M
2025-03-31-$56.17M-$48.86M$262,000.00$69.11M$498,000.00
2024-12-31-$49.73M-$47.66M$209,000.00$39.13M$102,000.00
2024-09-30-$57.76M
2024-06-30-$55.85M
2024-03-31-$46.96M-$30.27M$1.49M$59.55M$21.79M
2023-12-31-$41.11M-$25.1M$61,000.00$31.92M$219,000.00
2023-09-30-$41.49M
2023-06-30-$41.19M
2023-03-31-$37.55M-$30.28M$163,000.00-$174.21M$273.33M
2022-12-31-$35.06M-$31.24M$166,000.00$20.02M$284,000.00
2022-09-30-$30.62M
2022-06-30-$29.55M
2022-03-31-$28.1M-$20.5M$644,000.00$1.53M-$153,000.00
2021-12-31-$24.53M-$19.87M$592,000.00$25.78M$516,000.00
2021-09-30-$27.05M
2021-06-30-$22.83M
2021-03-31-$22.86M-$13.67M$242,000.00$12.23M$1.37M
2020-12-31-$19.03M-$16.49M$587,000.00$11.91M$237,000.00
2020-09-30-$16.53M
2020-06-30-$17M
2020-03-31$11.03M-$12.77M$336,000.00-$11.37M$51.7M
2019-12-31$42.17M$36.74M$184,000.00-$9.18M$46.83M
2019-09-30-$13.26M
2019-06-30-$15.52M
2019-03-31-$14.02M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$149.34M-$128.34M$374,000.00$134.29M-$31.7M
2024-12-31-$210.3M-$155.5M$3.85M$140.34M$23.12M
2023-12-31-$161.34M-$116.36M$921,000.00-$127.01M$274.41M
2022-12-31-$123.32M-$94.63M$1.76M-$150.2M$226.85M
2021-12-31-$97.26M-$75.44M$1.95M$73.7M$2.53M
2020-12-31-$41.53M-$37.27M$1.53M-$210.87M$213.21M
2019-12-31-$631,000.00-$2.75M$964,000.00-$17.93M$45.54M